3-Bromo-5-cyclopropylmethoxy-7-fluoro-5-trifluoromethyl-5,10-dihydro-benzo[b][1,8]naphthyridine 1-oxide | 335448-88-9

• 分子结构分类: 有机化合物 - 有机杂环化合物 - 喹啉及其衍生物
• 英文名称: 3-Bromo-5-cyclopropylmethoxy-7-fluoro-5-trifluoromethyl-5,10-dihydro-benzo[b][1,8]naphthyridine 1-oxide
• CAS: 335448-88-9
• 化学式: C₁₇H₁₃BrF₄N₂O₂
• 分子量: 433.2
• InChiKey: CVYDVLNSZLTGNG-UHFFFAOYSA-N

计算性质

• 辛醇/水分配系数(LogP)：
  4.51
• 重原子数：
  26.0
• 可旋转键数：
  3.0
• 环数：
  4.0
• sp3杂化的碳原子比例：
  0.35
• 拓扑面积：
  48.2
• 氢给体数：
  1.0
• 氢受体数：
  3.0

文献信息

• Tricyclic compounds useful as HIV reverse transcriptase inhibitors
  申请人：——

  公开号：US20040002498A1

  公开（公告）日：2004-01-01

  The present invention relates to tricyclic compounds of formula (I): 1 or stereoisomeric forms, stereoisomeric mixtures, or pharmaceutically acceptable salt forms thereof, which are useful as inhibitors of HIV reverse transcriptase, and to pharmaceutical compositions and diagnostic kits comprising the same, and methods of using the same for treating viral infection or as an assay standard or reagent.

  本发明涉及公式（I）的三环化合物：1或其立体异构体形式，立体异构体混合物或其药学上可接受的盐形式，其可用作HIV反转录酶的抑制剂，以及包含其的制药组合物和诊断工具箱，以及使用其治疗病毒感染或作为测定标准或试剂的方法。
• Novel androgens
  申请人：——

  公开号：US20030100543A1

  公开（公告）日：2003-05-29

  The disclosed invention relates to the unexpected finding of novel steroids which are characterized by a 14&bgr;,15&bgr;-cyclopropane ring and a 17&agr; hydroxymethyl group. These steroids according to the invention are found to have in common an androgenic activity. They can be used for the preparation of an agent for male contraception, as well as for the preparation of a medicament for the treatment of androgen insufficiency.

  本公开发明涉及一种意外发现的新型类固醇，其特征为具有14&bgr;，15&bgr;-环丙烷环和17&agr;羟甲基基团。根据本发明，这些类固醇具有共同的雄激素活性。它们可用于制备男性避孕剂，以及用于制备治疗雄激素不足的药物。
• CONDENSED NAPHTHYRIDINES AS HIV REVERSE TRANSCRIPTASE INHIBITORS
  申请人：Bristol-Myers Squibb Pharma Company

  公开号：EP1222186A2

  公开（公告）日：2002-07-17
• COMPOSITIONS AND METHODS FOR TREATMENT OF FILOVIRUS-MEDIATED DISEASES
  申请人：Johansen Lisa M.

  公开号：US20110028564A1

  公开（公告）日：2011-02-03

  The invention features compositions, methods, and kits useful for the treatment of filovirus-mediated diseases, e.g., hemorrhagic fever caused by Ebola virus, in an animal.
• US6593337B1
  申请人：——

  公开号：US6593337B1

  公开（公告）日：2003-07-15